Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GILL L FREI

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1477541761
CMS profile
157806
Location
BRONX, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$873.01

41 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $757.90 40
Consulting Fee $115.11 1

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 1; records 1–41 of 41 matching records. This page contains 41 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GILL L FREI

NPI 1477541761 · CMS profile ID 157806

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

BRONX, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–41 of 41 matching records. This page contains 41 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1477541761?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GILL L FREI, NPI 1477541761, CMS profile ID 157806. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–41 of 41 matching records. This page contains 41 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1477541761?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). GILL L FREI, NPI 1477541761, CMS profile ID 157806. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–41 of 41 matching records. This page contains 41 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1477541761?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
GILL L FREI, NPI 1477541761, CMS profile ID 157806, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–41 of 41 matching records. This page contains 41 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1477541761?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

41 matching records · $873.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 41 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–41 of 41.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $15.4812/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685410007 CMS
Relypsa, Inc. $18.1412/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683910699 CMS
AKEBIA THERAPEUTICS INC $19.5812/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706562017 CMS
Amgen Inc. $36.2812/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662363969 CMS
Horizon Therapeutics plc $17.4611/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691377297 CMS
AstraZeneca Pharmaceuticals LP $18.3111/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685190009 CMS
Relypsa, Inc. $22.6211/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683917779 CMS
Amgen Inc. $17.7310/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662363967 CMS
Merck Sharp & Dohme Corporation $16.5510/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695813391 CMS
Relypsa, Inc. $15.1010/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683905105 CMS
Relypsa, Inc. $19.4810/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683925029 CMS
Amgen Inc. $21.0509/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662363965 CMS
Horizon Therapeutics plc $19.6309/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691377293 CMS
PFIZER INC. $18.4808/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673206951 CMS
Retrophin, Inc. $29.7708/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701826319 CMS
AKEBIA THERAPEUTICS INC $21.7608/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706562015 CMS
Amgen Inc. $20.6207/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662363963 CMS
Amgen Inc. $29.7107/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662363961 CMS
AstraZeneca Pharmaceuticals LP $20.3507/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685213321 CMS
Mallinckrodt Enterprises LLC $30.6607/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704781113 CMS
AstraZeneca Pharmaceuticals LP $16.5706/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685659793 CMS
Fresenius USA Marketing, Inc. $17.9506/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701843163 CMS
Fresenius USA Marketing, Inc. $1.0706/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701843239 CMS
Mallinckrodt Enterprises LLC $18.3306/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704781111 CMS
Relypsa, Inc. $16.8106/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683908331 CMS
Fresenius USA Marketing, Inc. $115.1105/16/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701832677 CMS
Relypsa, Inc. $13.3305/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683901247 CMS
Mallinckrodt Enterprises LLC $16.5704/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704781109 CMS
AKEBIA THERAPEUTICS INC $34.8804/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706562013 CMS
AstraZeneca Pharmaceuticals LP $17.4304/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685705585 CMS
Relypsa, Inc. $12.9004/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683900449 CMS
Alexion Pharmaceuticals, Inc. $17.2204/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695616001 CMS
AKEBIA THERAPEUTICS INC $23.1003/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706562009 CMS
Relypsa, Inc. $11.2903/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683898129 CMS
Mallinckrodt Enterprises LLC $17.9502/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704781107 CMS
ARBOR PHARMACEUTICALS, INC. $15.7902/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697362043 CMS
PFIZER INC. $15.2002/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673211093 CMS
Relypsa, Inc. $14.6802/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683904115 CMS
Merck Sharp & Dohme Corporation $16.8501/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695222485 CMS
Relypsa, Inc. $12.3601/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683899525 CMS
AKEBIA THERAPEUTICS INC $18.8601/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706562011 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $873.01 41
PY2020 $384.55 19
PY2021 $465.75 23
PY2022 $176.17 9
PY2023 $271.66 13
PY2024 $340.49 14
PY2025 $559.27 21

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $6,555.00 5
PY2020 Principal investigator $68,056.25 24
PY2019 Principal investigator $110,031.15 206

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

206 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AKEBIA THERAPEUTICS INC $200.00 12/20/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131881
Principal investigator 1 AKEBIA THERAPEUTICS INC $200.00 12/12/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131879
Principal investigator 1 AKEBIA THERAPEUTICS INC $684.30 12/11/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131875
Principal investigator 1 AKEBIA THERAPEUTICS INC $207.80 12/11/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131877
Principal investigator 1 AKEBIA THERAPEUTICS INC $393.64 12/10/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131873
Principal investigator 1 AKEBIA THERAPEUTICS INC $752.00 12/10/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195169
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 12/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195159
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,440.00 12/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195161
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,440.00 12/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195163
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,200.00 12/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195165
Principal investigator 1 AKEBIA THERAPEUTICS INC $720.00 12/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195167
Principal investigator 1 AKEBIA THERAPEUTICS INC $828.00 12/05/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195153
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 12/05/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195155
Principal investigator 1 AKEBIA THERAPEUTICS INC $387.00 12/05/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195157
Principal investigator 1 AKEBIA THERAPEUTICS INC $100.00 12/04/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131867
Principal investigator 1 AKEBIA THERAPEUTICS INC $150.00 12/04/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131869
Principal investigator 1 AKEBIA THERAPEUTICS INC $90.00 12/04/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131871
Principal investigator 1 AKEBIA THERAPEUTICS INC $20.00 12/03/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707192433
Principal investigator 1 AKEBIA THERAPEUTICS INC $200.00 11/25/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131863
Principal investigator 1 AKEBIA THERAPEUTICS INC $480.00 11/25/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131865
Principal investigator 1 AKEBIA THERAPEUTICS INC $393.64 11/19/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131857
Principal investigator 1 AKEBIA THERAPEUTICS INC $332.48 11/19/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131859
Principal investigator 1 AKEBIA THERAPEUTICS INC $90.00 11/19/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131861
Principal investigator 1 AKEBIA THERAPEUTICS INC $332.48 11/15/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131855
Principal investigator 1 AKEBIA THERAPEUTICS INC $300.00 11/14/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131853
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 11/12/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131851
Principal investigator 1 AKEBIA THERAPEUTICS INC $166.24 11/11/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131847
Principal investigator 1 AKEBIA THERAPEUTICS INC $5.44 11/11/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131849
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 11/04/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707192425
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,440.00 11/04/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707192427
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,440.00 11/04/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707192429
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,440.00 11/04/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707192431
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 10/22/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131845
Principal investigator 1 AKEBIA THERAPEUTICS INC $684.30 10/21/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131841
Principal investigator 1 AKEBIA THERAPEUTICS INC $415.60 10/21/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131843
Principal investigator 1 AKEBIA THERAPEUTICS INC $200.00 10/17/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131837
Principal investigator 1 AKEBIA THERAPEUTICS INC $90.00 10/17/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131839
Principal investigator 1 AKEBIA THERAPEUTICS INC $20.00 10/04/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707192423
Principal investigator 1 AKEBIA THERAPEUTICS INC $2,000.00 10/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0016 No dispute reported 06/30/2026 707195147
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,500.00 10/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0016 No dispute reported 06/30/2026 707195149
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,500.00 10/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0016 No dispute reported 06/30/2026 707195151
Principal investigator 1 AKEBIA THERAPEUTICS INC $159.00 09/27/2019 Non-covered Recipient Entity
NEPHROLOGY AND HYPERTENSION ASSOCIATES PC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707131883
Principal investigator 1 AKEBIA THERAPEUTICS INC $750.00 09/10/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707132721
Principal investigator 1 AKEBIA THERAPEUTICS INC $100.00 08/27/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131831
Principal investigator 1 AKEBIA THERAPEUTICS INC $60.00 08/27/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131833
Principal investigator 1 AKEBIA THERAPEUTICS INC $18.42 08/27/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131835
Principal investigator 1 AKEBIA THERAPEUTICS INC $892.00 08/27/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159701
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/27/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159703
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/27/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159705
Principal investigator 1 AKEBIA THERAPEUTICS INC $892.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159649
Principal investigator 1 AKEBIA THERAPEUTICS INC $892.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159651
Principal investigator 1 AKEBIA THERAPEUTICS INC $892.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159653
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159655
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159657
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159659
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159661
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159663
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159665
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159667
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159669
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159671
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159673
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159675
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159677
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159679
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159681
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159683
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159685
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159687
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159689
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159691
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159693
Principal investigator 1 AKEBIA THERAPEUTICS INC $387.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159695
Principal investigator 1 AKEBIA THERAPEUTICS INC $387.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159697
Principal investigator 1 AKEBIA THERAPEUTICS INC $387.00 08/06/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159699
Principal investigator 1 AKEBIA THERAPEUTICS INC $299.48 08/05/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131827
Principal investigator 1 AKEBIA THERAPEUTICS INC $64.99 08/05/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131829
Principal investigator 1 AKEBIA THERAPEUTICS INC $892.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159613
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159615
Principal investigator 1 AKEBIA THERAPEUTICS INC $816.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159617
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159619
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159621
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159623
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159625
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159627
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159629
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159631
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159633
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159635
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159637
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159639
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159641
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159643
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159645
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 08/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159647
Principal investigator 1 AKEBIA THERAPEUTICS INC $10.00 07/31/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131823
Principal investigator 1 AKEBIA THERAPEUTICS INC $393.64 07/31/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131825
Principal investigator 1 AKEBIA THERAPEUTICS INC $828.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159537
Principal investigator 1 AKEBIA THERAPEUTICS INC $752.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159539
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159541
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159543
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159545
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159547
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159549
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159551
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159553
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159555
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159557
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159559
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159561
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159563
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159565
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159567
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159569
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159571
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159573
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159575
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159577
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159579
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159581
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159583
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159585
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159587
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159589
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159591
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159593
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159595
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159597
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159599
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159601
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159603
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159605
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159607
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159609
Principal investigator 1 AKEBIA THERAPEUTICS INC $657.00 07/24/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159611
Principal investigator 1 AKEBIA THERAPEUTICS INC $50.00 07/23/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131809
Principal investigator 1 AKEBIA THERAPEUTICS INC $200.00 07/23/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131811
Principal investigator 1 AKEBIA THERAPEUTICS INC $90.00 07/23/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131813
Principal investigator 1 AKEBIA THERAPEUTICS INC $300.00 07/23/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131815
Principal investigator 1 AKEBIA THERAPEUTICS INC $240.00 07/23/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131817
Principal investigator 1 AKEBIA THERAPEUTICS INC $60.00 07/23/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131819
Principal investigator 1 AKEBIA THERAPEUTICS INC $299.48 07/23/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131821
Principal investigator 1 AKEBIA THERAPEUTICS INC $94.00 07/17/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131805
Principal investigator 1 AKEBIA THERAPEUTICS INC $64.99 07/17/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131807
Principal investigator 1 AKEBIA THERAPEUTICS INC $750.00 07/03/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707132715
Principal investigator 1 AKEBIA THERAPEUTICS INC $40.00 07/03/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707132717
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,500.00 07/03/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707132719
Principal investigator 1 AKEBIA THERAPEUTICS INC $20.00 07/01/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159535
Principal investigator 1 AKEBIA THERAPEUTICS INC $18.42 06/26/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131803
Principal investigator 1 AKEBIA THERAPEUTICS INC $10,050.00 06/10/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0016 No dispute reported 06/30/2026 707195145
Principal investigator 1 AKEBIA THERAPEUTICS INC $6.06 06/07/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131799
Principal investigator 1 AKEBIA THERAPEUTICS INC $64.99 06/07/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131801
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,246.80 05/29/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131789
Principal investigator 1 AKEBIA THERAPEUTICS INC $48.75 05/29/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131791
Principal investigator 1 AKEBIA THERAPEUTICS INC $60.00 05/29/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131793
Principal investigator 1 AKEBIA THERAPEUTICS INC $90.00 05/29/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131795
Principal investigator 1 AKEBIA THERAPEUTICS INC $60.00 05/29/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131797
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,440.00 05/20/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195143
Principal investigator 1 AKEBIA THERAPEUTICS INC $186.25 05/02/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131787
Principal investigator 1 AKEBIA THERAPEUTICS INC $200.00 05/02/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0017 No dispute reported 06/30/2026 707195141
Principal investigator 1 AKEBIA THERAPEUTICS INC $150.00 04/30/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131781
Principal investigator 1 AKEBIA THERAPEUTICS INC $160.00 04/30/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131783
Principal investigator 1 AKEBIA THERAPEUTICS INC $120.00 04/30/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131785
Principal investigator 1 AKEBIA THERAPEUTICS INC $200.00 04/09/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB6548CI0016 No dispute reported 06/30/2026 707195139
Principal investigator 1 AKEBIA THERAPEUTICS INC $10.00 04/02/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131775
Principal investigator 1 AKEBIA THERAPEUTICS INC $393.64 04/02/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131777
Principal investigator 1 AKEBIA THERAPEUTICS INC $90.00 04/02/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131779
Principal investigator 1 AKEBIA THERAPEUTICS INC $90.00 03/29/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131773
Principal investigator 1 AKEBIA THERAPEUTICS INC $17.25 03/25/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131765
Principal investigator 1 AKEBIA THERAPEUTICS INC $5.85 03/25/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131767
Principal investigator 1 AKEBIA THERAPEUTICS INC $88.81 03/25/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131769
Principal investigator 1 AKEBIA THERAPEUTICS INC $58.00 03/25/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131771
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 02/19/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159515
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 02/19/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159517
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 02/19/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159519
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 02/19/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159521
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 02/19/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159523
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 02/19/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159525
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 02/19/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159527
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 02/19/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159529
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 02/19/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159531
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 02/19/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159533
Principal investigator 1 AKEBIA THERAPEUTICS INC $521.50 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131727
Principal investigator 1 AKEBIA THERAPEUTICS INC $240.00 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131729
Principal investigator 1 AKEBIA THERAPEUTICS INC $10.90 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131731
Principal investigator 1 AKEBIA THERAPEUTICS INC $150.00 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131733
Principal investigator 1 AKEBIA THERAPEUTICS INC $200.00 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131735
Principal investigator 1 AKEBIA THERAPEUTICS INC $90.00 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131737
Principal investigator 1 AKEBIA THERAPEUTICS INC $480.00 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131739
Principal investigator 1 AKEBIA THERAPEUTICS INC $240.00 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131741
Principal investigator 1 AKEBIA THERAPEUTICS INC $927.04 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131743
Principal investigator 1 AKEBIA THERAPEUTICS INC $11.42 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131745
Principal investigator 1 AKEBIA THERAPEUTICS INC $442.29 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131747
Principal investigator 1 AKEBIA THERAPEUTICS INC $90.00 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131749
Principal investigator 1 AKEBIA THERAPEUTICS INC $43.50 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131751
Principal investigator 1 AKEBIA THERAPEUTICS INC $17.25 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131753
Principal investigator 1 AKEBIA THERAPEUTICS INC $17.55 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131755
Principal investigator 1 AKEBIA THERAPEUTICS INC $16.83 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131757
Principal investigator 1 AKEBIA THERAPEUTICS INC $10.65 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131759
Principal investigator 1 AKEBIA THERAPEUTICS INC $299.48 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131761
Principal investigator 1 AKEBIA THERAPEUTICS INC $11.00 01/18/2019 Non-covered Recipient Entity
KIDNEY MEDICAL ASSOCIATES, PLLC
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa (FO2RWARD-2) No dispute reported 06/30/2026 707131763
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 01/07/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159505
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 01/07/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159507
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 01/07/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159509
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 01/07/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159511
Principal investigator 1 AKEBIA THERAPEUTICS INC $250.00 01/07/2019 Non-covered Recipient Entity
TOTAL RENAL RESEARCH INC
AKB-6548-CI-0017 No dispute reported 06/30/2026 707159513